Most GLP-1 medications are designed to be kept in a cold environment, typically between 36F and 46F (2C to 8C)
This treatment should be positioned as a consultation-based service because not every mole, lesion, or skin growth is appropriate for cosmetic treatment without medical review
Systemic effects from retatrutide's mechanism: Based on the GLP-1/GIP/glucagon receptor class, potential adverse effects include nausea, vomiting, diarrhoea, reduced appetite, and gastrointestinal disturbance
For persistent belching or digestive discomfort that affects your quality of life or adherence to treatment, schedule a routine appointment with your healthcare provider
Early studies have also linked GLP-1s to improved cognition and reduced addictive behaviors, underscoring that these molecules are reshaping not just metabolic care but preventive and whole-body health